Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.

Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klövekorn W, Reinhold U, Tanner M, Gröne D, Deichmann M, Simon M, Hübinger F, Hofbauer G, Krähn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Hönigsmann H, Wernicke-Panten K, Hahn S, Pabst G, Voss D, Foguet M, Schmitz B, Lübbert H, Szeimies RM; AK-CT002 Study Group.; AK-CT003 Study Group..

Br J Dermatol. 2013 Apr;168(4):825-36. doi: 10.1111/bjd.12158.

2.

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.

Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klövekorn W, Reinhold U, Tanner M, Gröne D, Deichmann M, Simon M, Hübinger F, Hofbauer G, Krähn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Hönigsmann H, Wernicke-Panten K, Helwig C, Foguet M, Schmitz B, Lübbert H, Szeimies RM; AK-CT002 Study Group..

Br J Dermatol. 2012 Jan;166(1):137-46. doi: 10.1111/j.1365-2133.2011.10613.x. Epub 2011 Dec 21.

PMID:
21910711
3.

Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.

Neittaanmäki-Perttu N, Karppinen TT, Grönroos M, Tani TT, Snellman E.

Br J Dermatol. 2014 Nov;171(5):1172-80. doi: 10.1111/bjd.13326. Epub 2014 Oct 15.

PMID:
25109244
5.

Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.

Lee PK, Kloser A.

J Drugs Dermatol. 2013 Aug;12(8):925-30. Review.

PMID:
23986167
6.

Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data.

Szeimies RM, Stockfleth E, Popp G, Borrosch F, Brüning H, Dominicus R, Mensing H, Reinhold U, Reich K, Moor AC, Stocker M, Ortland C, Brunnert M, Hauschild A.

Br J Dermatol. 2010 Feb 1;162(2):410-4. doi: 10.1111/j.1365-2133.2009.09377.x. Epub 2009 Jun 30.

PMID:
19804593
7.

Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.

Rubel DM, Spelman L, Murrell DF, See JA, Hewitt D, Foley P, Bosc C, Kerob D, Kerrouche N, Wulf HC, Shumack S.

Br J Dermatol. 2014 Nov;171(5):1164-71. doi: 10.1111/bjd.13138. Epub 2014 Oct 20.

PMID:
24861492
8.

Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.

Hauschild A, Stockfleth E, Popp G, Borrosch F, Brüning H, Dominicus R, Mensing H, Reinhold U, Reich K, Moor AC, Stocker M, Ortland C, Brunnert M, Szeimies RM.

Br J Dermatol. 2009 May;160(5):1066-74. doi: 10.1111/j.1365-2133.2009.09040.x. Epub 2009 Feb 16.

PMID:
19222455
9.

Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses.

Braathen LR, Paredes BE, Saksela O, Fritsch C, Gardlo K, Morken T, Frølich KW, Warloe T, Solér AM, Ros AM.

J Eur Acad Dermatol Venereol. 2009 May;23(5):550-5.

PMID:
19415804
10.

A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp.

Zane C, Facchinetti E, Rossi MT, Specchia C, Calzavara-Pinton PG.

Br J Dermatol. 2014 May;170(5):1143-50. doi: 10.1111/bjd.12844.

PMID:
24506666
11.

Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis.

Gholam P, Weberschock T, Denk K, Enk A.

Dermatology. 2011;222(4):358-62. doi: 10.1159/000329025. Epub 2011 Jul 12.

PMID:
21757880
12.

Update on photodynamic treatment for actinic keratosis.

Wiegell SR.

Curr Probl Dermatol. 2015;46:122-8. doi: 10.1159/000366548. Epub 2014 Dec 18.

PMID:
25561216
13.

Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.

Wiegell SR, Haedersdal M, Eriksen P, Wulf HC.

Br J Dermatol. 2009 Jun;160(6):1308-14. doi: 10.1111/j.1365-2133.2009.09119.x. Epub 2009 Mar 26.

PMID:
19416257
14.

Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.

Lacour JP, Ulrich C, Gilaberte Y, Von Felbert V, Basset-Seguin N, Dreno B, Girard C, Redondo P, Serra-Guillen C, Synnerstad I, Tarstedt M, Tsianakas A, Venema AW, Kelleners-Smeets N, Adamski H, Perez-Garcia B, Gerritsen MJ, Leclerc S, Kerrouche N, Szeimies RM.

J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2342-8. doi: 10.1111/jdv.13228. Epub 2015 Oct 5.

PMID:
26435363
15.

Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.

Fargnoli MC, Piccioni A, Neri L, Tambone S, Pellegrini C, Peris K.

J Eur Acad Dermatol Venereol. 2015 Oct;29(10):1926-32. doi: 10.1111/jdv.13076. Epub 2015 Mar 23.

PMID:
25809617
16.

Long-term follow-up of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.

Babilas P.

Br J Dermatol. 2013 Apr;168(4):686-7. doi: 10.1111/bjd.12246. No abstract available.

PMID:
23528055
17.

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study.

Szeimies RM, Radny P, Sebastian M, Borrosch F, Dirschka T, Krähn-Senftleben G, Reich K, Pabst G, Voss D, Foguet M, Gahlmann R, Lübbert H, Reinhold U.

Br J Dermatol. 2010 Aug;163(2):386-94. doi: 10.1111/j.1365-2133.2010.09873.x. Epub 2010 May 28.

PMID:
20518784
18.

Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study.

Ko DY, Jeon SY, Kim KH, Song KH.

J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1529-39. doi: 10.1111/jdv.12334. Epub 2013 Dec 17.

PMID:
24341367
19.

Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.

Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB; Phase IV ALA-PDT Actinic Keratosis Study Group..

Br J Dermatol. 2006 Dec;155(6):1262-9.

PMID:
17107399
20.

Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.

Sotiriou E, Apalla Z, Maliamani F, Zaparas N, Panagiotidou D, Ioannides D.

J Eur Acad Dermatol Venereol. 2009 Sep;23(9):1061-5. doi: 10.1111/j.1468-3083.2009.03259.x. Epub 2009 Apr 8.

PMID:
19470041

Supplemental Content

Support Center